Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests

World Journal of Hepatology

Volumn 5, Issue 7, 2013, Pages 353-363

  Teschke, Rolf ^a   Frenzel, Christian ^b   Schulze, Johannes ^c   Schwarzenboeck, Alexander ^a   Eickhoff, Axel ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Herb induced liver injury; Herbal hepatotoxicity; Herbalife hepatotoxicity; Herbalife induced liver injury; Herbs

Indexed keywords

EID: 84884304537     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v5.i7.353     Document Type: Article

References (73)

1. Hoffmann M, Marbet UA, Hurni A, Bianchi L, Goldi H. Rezidiv einer medikamentos toxischen Hepatitis. Schweiz Med Forum 2005; 5: 147-148
2. Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, Keinan-Boker L, Broide E, Ackerman Z, Kaluski DN, Lev B, Shouval D. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 2007; 47: 514-520 [PMID: 17692424]
3. Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Reichen J, Zimmermann A, Oneta CM. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007; 47: 521-526 [PMID: 17692989]
4. Jóhannsson M, Ormarsdóttir S, Olafsson S. Hepatotoxicity associated with the use of Herbalife. Laeknabladid 2010; 96: 167-172 [PMID: 20197595]
5. Manso G, López-Rivas L, Salgueiro ME, Duque JM, Jimeno FJ, Andrade RJ, Lucena MI. Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injury. Pharmacoepidemiol Drug Saf 2011; 20: 1080-1087 [PMID: 21751292 DOI: 10.1002/pds.2180]
6. Duque JM, Ferreiro J, Salgueiro E, Manso G. Hepatotoxicity associated with the consumption of herbal slimming products. Med Clin (Barc) 2007; 128: 238-239 [PMID: 17335732]
7. Chao S, Anders M, Turbay M, Olaiz E, Mc Cormack L, Mastai R. Toxic hepatitis by consumption Herbalife products a case report. Acta Gastroenterol Latinoam 2008; 38: 274-277 [PMID: 19157382]
8. Stickel F, Droz S, Patsenker E, Bögli-Stuber K, Aebi B, Leib SL. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol 2009; 50: 111-117 [PMID: 19010564 DOI: 10.1016/ j.jhep.2008.08.017]
9. Chen GC, Ramanathan VS, Law D, Funchain P, Chen GC, French S, Shlopov B, Eysselein V, Chung D, Reicher S, Pham BV. Acute liver injury induced by weight-loss herbal supplements. World J Hepatol 2010; 2: 410-415 [PMID: 21173910 DOI: 10.4254/wjh.v2.i11.410]
10. Ramanathan VS, Hensley G, French S, Eysselein V, Chung D, Reicher S, Pham B. Hypervitaminosis A inducing intra-hepatic cholestasis--a rare case report. Exp Mol Pathol 2010; 88: 324-325 [PMID: 19944093 DOI: 10.1016/ j.yexmp.2009.11.007]
11. Stickel F. Slimming at all costs: Herbalife-induced liver in-jury. J Hepatol 2007; 47: 444-446 [PMID: 17692988]
12. Seeff LB. Are herbals as safe as their advocates believe? J Hepatol 2009; 50: 13-16 [PMID: 19017552 DOI: 10.1016/ j.jhep.2008.10.015]
13. Larrey D, Faure S. Herbal medicine hepatotoxicity: a new step with development of specific biomarkers. J Hepatol 2011; 54: 599-601 [PMID: 21167851 DOI: 10.1016/ j.jhep.2010.07.031]
14. García-Cortés M, Borraz Y, Lucena MI, Peláez G, Salmerón J, Diago M, Martínez-Sierra MC, Navarro JM, Planas R, Soria MJ, Bruguera M, Andrade RJ. Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 2008; 100: 688-695 [PMID: 19159172]
15. Stickel F, Kessebohm K, Weimann R, Seitz HK. Review of liver injury associated with dietary supplements. Liver Int 2011; 31: 595-605 [PMID: 21457433 DOI: 10.1111/ j.1478-3231.2010.02439.x]
16. Teschke R, Schwarzenboeck A, Eickhoff A, Frenzel C, Wolff A, Schulze J. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf 2013; 12: 339-366 [PMID: 23458441 DOI: 10.1517/14740338.2013.774371]
17. Ignarro L, Heber D, Henig YS, Bejar E. Herbalife nutritional products and liver injury revisited. J Hepatol 2008; 49: 291-293; author reply 293-294 [PMID: 18550201 DOI: 10.1016/j.jhep.2008.05.005]
18. Manso G, López-Rivas L, Duque JM, Salgueiro E. Spanish reports of hepatotoxicity associated with Herbalife products. J Hepatol 2008; 49: 289-290; author reply 290-291 [PMID: 18571274 DOI: 10.1016/j.jhep.2008.05.007]
19. Shouval D, Elinav E. More reports of potential hepatotoxicity of Herbalife products: Reply. J Hepatol 2008; 49: 290-291 [DOI: 10.1016/j.jhep.2008.05.010]
20. Appelhans K, Smith C, Bejar E, Henig YS. Revisiting acute liver injury associated with herbalife products. World J Hepatol 2011; 3: 275-277 [PMID: 22059112 DOI: 10.4254/wjh. v3.i10.275]
21. Bejar E, Smith CR, Appelhans K, Henig YS. Correcting a misrepresentation of hypervitaminosis A attributed to Herbalife product consumption. Exp Mol Pathol 2011; 90: 320-321; author reply 322 [PMID: 21315714 DOI: 10.1016/ j.yexmp.2011.02.001]
22. Appelhans K, Goldstein L. Revisiting liver injury associated with dietary supplements. Liver Int 2011; 31: 1239 [DOI: 10.1111/j.1478-3231.2011.02547.x]
23. Stickel F. Herbalife®-associated hepatotoxicity: author's reply. Liver Int 2011; 31: 1239-1240 [DOI: 10.1111/j.1478-3231. 2011.02568.x]
24. Appelhans K, Frankos V. Herbal medicine hepatotoxicity revisited. J Hepatol 2012; 56: 504-505; author reply 505 [PMID: 21782760 DOI: 10.1016/j.jhep.2011.06.019]
25. Larrey D, Faure S. Reply to: "Herbal medicine hepatotoxicity revisited". J Hepatol 2012; 56: 505 [DOI: 10.1016/ j.jhep.2011.07.003]
26. Appelhans K, Frankos V, Shao A. Misconceptions regarding the association between Herbalife products and liverrelated case reports in Spain. Pharmacoepidemiol Drug Saf 2012; 21: 333-334; author reply 335 [PMID: 22407600 DOI: 10.1002/pds.3203]
27. Manso G. Author's reply. Pharmacoepidemiol Drug Saf 2012; 21: 335 [DOI: 10.1002/pds.3201]
28. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376: 190-201 [PMID: 20638564 DOI: 10.1016/S0140-6736(10)60274-7]
29. Aithal GP, Rawlins MD, Day CP. Accuracy of hepatic adverse drug reaction reporting in one English health region. Br Med J 1999; 319: 154 [PMID: 10591713]
30. Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013 Mar 18; Epub ahead of print [PMID: 23510966]
31. Danan G. Causality assessment of drug-induced liver injury. Hepatology Working Group. J Hepatol 1988; 7: 132-136 [PMID: 3053889]
32. Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330 [PMID: 8229110]
33. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-1336 [PMID: 8229111]
34. Teschke R, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol 2013; 19: 2864-2882 [PMID: 23704820 DOI: 10.3748/wjg.v19.il9.2864]
35. García-Cortés M, Stephens C, Lucena MI, Fernández-Castañer A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 2011; 55: 683-691 [PMID: 21349301 DOI: 10.1016/ j.jhep.2011.02.007]
36. Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981; 282: 186-187 [PMID: 6779941]
37. Davies EG, Pollock I, Steel HM. Chinese herbs for eczema. Lancet 1990; 336: 117
38. Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991; 337: 372-373 [PMID: 1671276]
39. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, Michel H. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117: 129-132 [PMID: 1605427]
40. Perharic-Walton L, Murray V. Toxicity of Chinese herbal remedies. Lancet 1992; 340: 674 [PMID: 1355235]
41. Woolf GM, Petrovic LM, Rojter SE, Wainwright S, Villamil FG, Katkov WN, Michieletti P, Wanless IR, Stermitz FR, Beck JJ, Vierling JM. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994; 121: 729-735 [PMID: 7944049]
42. Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995; 90: 831-833 [PMID: 7733101]
43. Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chaihu-tang). Dig Dis Sci 1995; 40: 1845-1848 [PMID: 7648990]
44. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995; 36: 146-147 [PMID: 7890220]
45. Horowitz RS, Feldhaus K, Dart RC, Stermitz FR, Beck JJ. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996; 156: 899-903 [PMID: 8774209]
46. Laliberté L, Villeneuve JP. Hepatitis after the use of germander, a herbal remedy. CMAJ 1996; 154: 1689-1692 [PMID: 8646656]
47. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, mahuang. Am J Gastroenterol 1996; 91: 1436-1438 [PMID: 8678010]
48. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr 1998; 123: 1410-1414 [PMID: 9856112]
49. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 1999; 117: 1234-1237 [PMID: 10535888]
50. Stickel F, Pöschl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D. Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003; 38: 565-568 [PMID: 12795472]
51. Yang L, Aronsohn A, Hart J, Jensen D. Herbal hepatoxicity from Chinese skullcap: A case report. World J Hepatol 2012; 4: 231-233 [PMID: 22855699 DOI: 10.4254/wjh.v4.i7.231]
52. World Health Organization. The use of the WHO-UMC system for standardised case causality assessment. WHO Collaborating Centre for International Drug Monitoring (Uppsala Monitoring Centre, UMC), Database 2000. Accessed 15 January 2013. Available from: URL: http://whoumc.org/Graphics/24734.pdf
53. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247-254 [PMID: 837643]
54. Teschke R, Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Regul Toxicol Pharmacol 2011; 59: 1-7 [PMID: 20854865 DOI: 10.1016/j.yrtph.2010.09.006]
55. Teschke R, Frenzel C, Schulze J, Eickhoff A. Suspected herbal hepatotoxicity: The pharmacovigilance dilemma with disputed and obsolete evaluation methods. Regul Toxicol Pharmacol 2012; 64: 343-344 [PMID: 22732127]
56. Teschke R, Eickhoff A, Wolff A, Frenzel C, Schulze J. Herbal hepatotoxicity and WHO global introspection method. Ann Hepatol 2013; 12: 11-21 [PMID: 23293189]
57. Kramer MS. Assessing causality of adverse drug reactions: Global introspection and its limitations. Drug Inf J 1986; 20: 433-437
58. Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013; 75: 630-636 [PMID: 22831551 DOI: 10.1111/j.1365-2125.2012.04395.x]
59. Teschke R, Frenzel C, Schulze J, Eickhoff A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 2012; 63: 1-9 [PMID: 22381150 DOI: 10.1016/j.yrtph.2012.02.009]
60. Teschke R, Frenzel C, Wolff A, Herzog J, Glass X, Schulze J, Eickhoff A. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. Ann Hepatol 2012; 11: 500-512 [PMID: 22700632]
61. Stammschulte T, Gundert-Remy U. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul Toxicol Pharmacol 2012; 64: 342; author reply 343-344 [PMID: 22728685 DOI: 10.1016/j.yrtph.2012.06.011]
62. Andrade RJ, Camargo R, Lucena MI, González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 2004; 3: 329-344 [PMID: 15268650 DOI: 10.1517/14740338.3.4.329]
63. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, González-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-521 [PMID: 16083708]
64. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012; 32: 1543-1556 [PMID: 22928722 DOI: 10.1111/ j.1478-3231.2012.02864.x]
65. National Institutes of Health. NIH launches free database of drugs associated with liver injury, October 12, 2012 News Release. Accessed 15 January 2013. Available from: URL: http://www.nih.gov/news/health/oct2012/niddk-12.htm
66. National Institutes of Health and LiverTox: Drug record. Herbals and dietary supplements. Last updated 20 February 2012. Accessed 15 January 2013. Available from: URL: http://www.livertox.nih.gov/Herbals_and_Dietary_Supplements.htm
67. Navarro VJ, Barnhart HX, Bonkovsky HL, Reddy KR, Seeff L, Serrano J, Talwalkar JA, Vega M, Vuppalanchi R. Diagnosing hepatotoxicity attributable to herbal and dietary supplements (HDS): test-retest reliability of a novel causality assessment tool. J Hepatol 2012; 56 (Suppl 2): S536 [DOI: 10.1016/S0168-8278(12)61375-0]
68. Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 2013; 37: 3-17 [PMID: 23121117 DOI: 10.1111/apt.12109]
69. Appelhans K, Najeeullah R, Frankos V. Letter: retrospective reviews of liver-related case reports allegedly associated with Herbalife present insufficient and inaccurate data. Aliment Pharmacol Ther 2013; 37: 753-754 [PMID: 23458533 DOI: 10.1111/apt.12217]
70. Reddy KR, Bunchorntavakul C. Letter: retrospective reviews of liver-related case reports allegedly associated with Herbalife present insufficient and inaccurate data--authors' reply. Aliment Pharmacol Ther 2013; 37: 754-755 [PMID: 23458534 DOI: 10.1111/apt.12242]
71. Agarwal VK, McHutchison JG, Hoofnagle JH; Drug-Induced Liver Injury Network. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol 2010; 8: 463-470 [PMID: 20170750 DOI: 10.1016/ j.cgh.2010.02.008]
72. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, Remnarace R, Ijaz S, Hussaini SH, Bendall RP. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429-1435 [PMID: 17850420 DOI: 10.1111/ j.1365-2036.2007.03504.x]
73. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH. Acute hepatitis E infection accounts for some cases of suspected druginduced liver injury. Gastroenterology 2011; 141: 1665-1672. e1-9 [PMID: 21855518 DOI: 10.1053/j.gastro.2011.07.051]